Imagine a tiny, powerful flashlight that can shoot a beam of energy deep into the body to destroy a tumor without hurting the healthy skin or organs around it. Current machines are huge and expensive, but this project uses lasers to shrink the technology down. It's like replacing a giant industrial furnace with a precise, compact microwave for cancer treatment.
Current radiotherapy is limited by toxicity to healthy tissues and is often too expensive or bulky, making it difficult to treat deep-tissue tumors or obese patients effectively.
An electron source prototype and a dedicated laboratory space to demonstrate the technical feasibility of a compact VHEE beam.
If you are a medical device company dealing with the high cost and size of traditional linear accelerators — this project developed a compact laser plasma accelerator that makes the machinery small and cost-effective. This allows for a more accessible device for hospitals.
If you are a clinic dealing with the inability to treat obese patients or deep-tissue tumors due to toxicity risks — this project developed a VHEE beam prototype that improves 3D dose deposition. This enables treating deeper tumors with fewer side effects.
If you are an investor dealing with the need for disruptive cancer therapies that reduce the financial burden on payers — this project developed a technically feasible electron source prototype. It aims to lower the cost of delivery while improving clinical outcomes.
Based on available project data, the specific price is not listed, but the project aims to create a 'cost-effective' and 'economically competitive' alternative to current radiotherapy modalities.
The project is currently building an electron source prototype to demonstrate technical feasibility; it is not yet at full industrial scale.
Based on available project data, there is no specific mention of licensing terms, though the project involves a consortium with an industry partner to speed up market entry.
The project period runs from 2022-08-01 to 2026-01-31, focusing on prototype development and commercial feasibility validation.
The project focuses on scaling down components to make the machinery small and simple, which would theoretically make it easier to integrate than current bulky RT equipment.
The consortium is a lean 2-partner operation consisting of one university (Weizmann Institute of Science) and one SME. With an industry ratio of 50%, the project is well-balanced between academic research and commercial application, ensuring that the technical development of the laser plasma accelerator is aligned with market needs.
Contact the Weizmann Institute of Science research office regarding the ebeam4therapy project.
Contact us to explore licensing opportunities for compact laser plasma accelerators.
